Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Summit Therapeu ADR (SMMT)

Summit Therapeu ADR (SMMT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Summit Therapeu ADR 136a Eastern Avenue Milton Park Abingdon X0 OX144SB GBR

P: 44-12-3544-3939

Description:

Summit Therapeutics PLC is engaged in the discovery and development of drug to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit Therapeutics PLC is headquartered in Abingdon, the United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 76,398
Shares Outstanding, K 32,100
Annual Sales, $ 57,060 K
Annual Net Income, $ 9,990 K
Last Quarter Sales, $ 150 K
Last Quarter Net Income, $ -8,710 K
60-Month Beta -0.07
% of Institutional Shareholders 8.55%
Float, K 32,100
% Float 100.00%

Growth:

1-Year Return 30.15%
3-Year Return -78.98%
5-Year Return -81.11%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 04/08/20
Earnings Per Share ttm -1.00
EPS Growth vs. Prev Qtr -25.00%
EPS Growth vs. Prev Year 61.54%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

SMMT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 2.24
Price/Earnings to Growth N/A
Return-on-Equity % -59.95%
Return-on-Assets % -42.26%
Profit Margin % 17.51
Net Margin % N/A
Debt/Equity 0.02
Price/Sales 56.77
Price/Cash Flow 2.11
Price/Book 2.29
Book Value/Share 1.04
Interest Coverage 12.91
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar